Chemistry:Estriol sulfamate
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | Estriol 3-O-sulfamate; J1034; E3MATE; Estra-1,3,5(10)-triene-3,16α,17β-triol 3-sulfamate; 16α,17β-Dihydroxyestra-1,3,5(10)-trien-3-yl sulfamate |
| Routes of administration | By mouth[1][2] |
| Drug class | Estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H25NO5S |
| Molar mass | 367.46 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estriol sulfamate (developmental code name J1034), or estriol 3-O-sulfamate, is a synthetic estrogen and estrogen ester which was never marketed.[1][2][3] It is the C3 sulfamate ester of estriol.[1][2] The drug shows substantially improved oral estrogenic potency (vagina, uterus) relative to estriol in rats but without an increase in hepatic estrogenic potency.[1] However, the closely related compound estradiol sulfamate (E2MATE) failed to show estrogenic activity in humans, which is due to the fact that it is additionally a highly potent inhibitor of steroid sulfatase which regulates the estrogenicity of such compounds[4] and thus it prevents its own bioactivation into estradiol.[5]
See also
References
- ↑ 1.0 1.1 1.2 1.3 "Novel oestrogen sulfamates: a new approach to oral hormone therapy". Expert Opin Investig Drugs 7 (4): 575–89. April 1998. doi:10.1517/13543784.7.4.575. PMID 15991994.
- ↑ 2.0 2.1 2.2 "17Beta-hydroxy-11alpha-(3'-sulfanylpropyl)oxy-estra-1,3,5(10)- trien-3-yl sulfamate--a novel hapten structure: toward the development of a specific enzyme immunoassay (EIA) for estra-1,3,5(10)-triene-3-yl sulfamates". Steroids 64 (7): 460–71. July 1999. doi:10.1016/s0039-128x(99)00020-3. PMID 10443902.
- ↑ Schwarz, S., Elger, W., Siemann, H. J., Reddersen, G., & Schneider, B. (2000). U.S. Patent No. 6,080,735. Washington, DC: U.S. Patent and Trademark Office. https://patents.google.com/patent/US6080735A/en
- ↑ Chander, S K, A Purohit, L W L Woo, B V L Potter and M J Reed (2004). "The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.". Biochem. Biophys. Res. Commun. 322 (1): 217–222. doi:10.1016/j.bbrc.2004.07.108. PMID 15313194.
- ↑ "Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions". J. Steroid Biochem. Mol. Biol. 165 (Pt B): 305–311. January 2017. doi:10.1016/j.jsbmb.2016.07.008. PMID 27449818.
 |  |
